There are no announcements yet.
Asthma is a chronic disease of the airways in which breathing becomes difficult due to inflammation of the air passages, resulting in a temporary narrowing of the airways that deliver oxygen to the lungs. It can be brought on my many factors, including allergens, exercise, smoke (tobacco or otherwise), perfumes, changes in humidity, and strong emotions such as anxiety, laughing, or crying. When the airways become irritated due to animal fur or dander, pollen, dust, or fumes, they narrow and cause coughing and wheezing. The bronchial tubes of those with asthma are red and swollen, or inflamed, and exercise aggravates this effect. Asthma can occur at any age, but is increasingly prevalent in children. In fact, nearly one in 10 American children now has asthma. Asthma causes 4,000 deaths a year in the United States. Medicines such as inhaled short-acting beta-2 agonists may be used to treat acute attacks.
Since cannabinoids has been found to reduce inflammation, it can be extremely beneficial to those with asthma. A study done by Hartley, Nogrady, and Seaton that was published in the "British Journal of Clinical Pharmacology" entitled "Bronchodilator Effect of Δ1-Tetrahydrocannabinol" found:
1. Δ1-trans-tetrahydrocannabinol, (Δ1-THC) produces bronchodilatation in asthmatic patients.
2. Administered in 62 microliter metered volumes containing 50-200 microgram by inhalation from an aerosol device to patients judged to be in a steady state, it increased peak expiratory flow rate (PEFR) and forced expiratory volume in 1 second (FEV1).
3. The rate of onset, magnitude, and duration of the bronchodilator effect was dose related.
STC is regulated by the Securities and Exchange Commission
2901 N Dallas Parkway
Suite 380
Plano, Texas 75093
(469) 633-0101
FINAL Updated CSi – First Rights DATES !!!
*** March 31, 2021 is the Last Day for the CSi First Rights offering.
We need to begin the Cannabis...FINAL Updated CSi – First Rights DATES !!!
*** March 31, 2021 is the Last Day for the CSi First Rights offering.
We need to begin the Cannabis Science CSi share exchange with Omnicanna, so this is it.
As promised, we are reaching out to every email from every shareholder responding to the CSi- FR opportunity, Thanks for your patience. This extra time will allow us to do so. This will be the last extension as we need to begin the Cannabis Science share exchange and issue the first batch of the CSi – First Rights shares in ENDO immediately.
*** As planned, beginning March 1, 2021, we are now completing the paperwork and beginning to issue the first batch of CSi-First Rights ENDO shares right now.
If you have not already sent in your paperwork, please do now to be a part of this first group of share issuances. Otherwise, all the Best, we expect your Cannabis Science shares to do very well, as well !!!
We are booked solid though to mid-March at this point, if you book a call you will be included, so just book something before the end of March 2021 and you will be included.
We will announce the next update on this matter as we begin to issue this first batch of CSi-FR ENDO shares and make announcements for the first batch of CSi – ENDO share exchange shares right behind it.
Cheers!
Stay Safe and Strong.
Talk soon.
Raymond
Show more
Yes. Shares will automatically update. less than a minute ago